SUTRO BIOPHARMA INC (STRO) Stock Cash Flow
NASDAQ:STRO - Nasdaq - US8693671021 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -123.95M | -106.79M | -119.20M | -105.54M | -32.13M | |||
| Depreciation Amortization | 7.08M | 6.82M | 5.69M | 4.84M | 4.30M | |||
| Change In Working Capital | 3.05M | -34.38M | 104.41M | -17.62M | -11.49M | |||
| Interest Paid | 219.00K | 1.13M | 1.87M | 2.05M | 1.68M | |||
| Taxes Paid | N/A | 379.00K | 0.00 | 100.00K | N/A | |||
| Other non cash items | 8.09M | 22.74M | 12.66M | 36.64M | -28.49M | |||
| OPERATING CASH FLOW | -105.73M | -111.62M | 3.55M | -81.68M | -67.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.48M | -4.32M | -7.86M | -15.32M | -7.13M | |||
| Other Investing Activity | 110.98M | 391.00K | -27.16M | -81.99M | 7.73M | |||
| INVESTING CASH FLOW | 107.51M | -3.92M | -35.02M | -97.32M | 600.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -7.20M | -12.50M | -9.38M | 0.00 | 15.00M | |||
| Stock Issued/Repurchased | 96.59M | 12.29M | 58.15M | 2.48M | 254.56M | |||
| Other Financing Activity | 1.56M | 137.77M | -460.00K | 780.00K | -310.00K | |||
| FINANCING CASH FLOW | 90.95M | 137.55M | 48.31M | 3.26M | 269.25M | |||
| CHANGE IN CASH | 92.73M | 22.01M | 16.84M | -175.74M | 202.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -105.73M | -111.62M | 3.55M | -81.68M | -67.80M | |||
| Capital Expenditure | -3.48M | -4.32M | -7.86M | -15.32M | -7.13M | |||
| FREE CASH FLOW | -109.20M | -115.93M | -4.31M | -97.00M | -74.93M | |||
All data in USD